[HTML][HTML] Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
D Intiso, AM Centra, M Gravina, A Chiaramonte… - Toxins, 2023 - mdpi.com
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
Botulinum Toxin-A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
D Intiso, AM Centra, M Gravina, A Chiaramonte… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke.
D Intiso, AM Centra, M Gravina, A Chiaramonte… - …, 2023 - search.ebscohost.com
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
D Intiso, AM Centra, M Gravina, A Chiaramonte… - Toxins, 2023 - search.proquest.com
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
[HTML][HTML] Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
D Intiso, AM Centra, M Gravina, A Chiaramonte… - Toxins, 2023 - ncbi.nlm.nih.gov
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
Botulinum Toxin-A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke.
D Intiso, AM Centra, M Gravina, A Chiaramonte… - Toxins, 2023 - europepmc.org
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …
Botulinum Toxin-A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke.
D Intiso, AM Centra, M Gravina, A Chiaramonte… - Toxins, 2023 - europepmc.org
Stroke patients can develop spasticity and spasticity-related pain (SRP). These disorders
are frequent and can contribute to functional limitations and disabling conditions. Many …
are frequent and can contribute to functional limitations and disabling conditions. Many …